Drugs & Diseases

Recent Drug Updates

  • moxidectin FDA approved moxidectin for the treatment of onchocerciasis (river blindness) in patients ≥12 years
  • pembrolizumab (Keytruda) First PD-1 inhibitor approved for adult and pediatric patients with refractory/relapsed PMBCL
  • bevacizumab (Avastin) New indication approved for the treatment of women with advanced ovarian cancer following initial surgical resection

Slideshow Collections

  • Gunshot Wounds: A Targeted Approach Every year, about 30,000 people are treated for gunshot wounds at US hospitals--roughly 8% will die from their wounds. Learn more about how to manage these patients and how wound treatment can differ by injury site.
  • Foreign Bodies: Curious Findings Common, curious, and often challenging, foreign bodies carry a unique set of presentations, risks, and treatment options. Can you identify these foreign bodies, and do you know the appropriate steps to take?
  • Multiple Sclerosis: Recognition, Differential Diagnosis, and Management Multiple sclerosis is a chronic, immune-mediated disease of the central nervous system that is characterized by inflammation, demyelination, and, ultimately, axonal loss. Learn more about clinical recognition, differential diagnosis, workup, and optimal treatment of this condition.
  • 23 Hidden Clues to Diagnosing Nutritional Deficiencies Many diseases are directly or indirectly caused by a lack of essential nutrients in the diet. Can you spot the hidden clues that indicate nutritional deficiencies?